Senior Research Fellow, University of South Australia
Dr Paul Joyce is Head of the Translational Nanomedicine & Biotherapeutics Group at the University of South Australia where his research focuses on utilising pharmaceutical science to transform therapeutic outcomes across a wide range of diseases, including cancer, mental health, metabolic syndrome, and antimicrobial resistance. Dr Joyce received his PhD in Pharmacy from the University of South Australia in 2016 where he was awarded a University Medal for Most Outstanding Thesis and the Norton Jackson Award for most outstanding research in materials science. Working at the interface of materials science and drug development, Dr Joyce engages closely with key stakeholders who enable clinical and commercial translation of his research, including the pharmaceutical industry, clinicians, and health consumers. Dr Joyce’s leadership within this field is evidenced through his publication of over 70 peer reviewed papers in leading international journals, 3 book chapters, and 3 granted international patents for novel nanomedicine inventions. Further, Dr Joyce is a Director of the Australian Controlled Release Society, the leading society for delivery science, and has been awarded over $9M in funding to support his research activities, including serving as a current Hospital Research Foundation Fellow and Cancer Council SA Fellow.